H.R. 10094 · 119th Congress (2025–2027)
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 10094’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Val T. Hoyle (D-OR-4)
- Cosponsors
15 cosponsors
7 original · 8 later
15 D
- Rep. Greg Casar (D-TX-35)· Original · Aug 13, 2026
- Rep. Lloyd Doggett (D-TX-37)· Original · Aug 13, 2026
- Rep. Pramila Jayapal (D-WA-7)· Original · Aug 13, 2026
- Del. Eleanor Holmes Norton (D-DC)· Original · Aug 13, 2026
- Rep. Melanie A. Stansbury (D-NM-1)· Original · Aug 13, 2026
- Rep. Mark Takano (D-CA-39)· Original · Aug 13, 2026
- Rep. Rashida Tlaib (D-MI-12)· Original · Aug 13, 2026
- Rep. Steve Cohen (D-TN-9)· Later · Aug 20, 2026
- Rep. Jesús G. "Chuy" García (D-IL-4)· Later · Aug 20, 2026
- Rep. Ro Khanna (D-CA-17)· Later · Aug 20, 2026
- Rep. Jill N. Tokuda (D-HI-2)· Later · Aug 20, 2026
- Rep. Janice D. Schakowsky (D-IL-9)· Later · Aug 27, 2026
- Rep. Seth Magaziner (D-RI-2)· Later · Aug 31, 2026
- Rep. Rosa L. DeLauro (D-CT-3)· Later · Sep 1, 2026
- Rep. Chellie Pingree (D-ME-1)· Later · Oct 9, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Display title, Short title · Introduced in House
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Official title · Introduced in House